NCT04131348View on ClinicalTrials.gov

Botulinum Toxin to Avoid Component Separation in Midline Large Hernias

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 1, 2018

Study Completion Date

October 1, 2019

Conditions
Botulinum Toxin Type ARives RepairLarge Midline HerniaComponent Separation
Interventions
PROCEDURE

botulinum toxin type A

From to December 2016 to December 2018, a single-center prospective comparative study was performed in 80 patients with LMIH at our tertiary center.

Trial Locations (1)

46008

Jose Bueno-Lledo, Valencia

All Listed Sponsors
lead

Hospital Universitario La Fe

OTHER

NCT04131348 - Botulinum Toxin to Avoid Component Separation in Midline Large Hernias | Biotech Hunter | Biotech Hunter